The API Innovation Center was recently featured in the Supply Chain Brain‘s news article “An Urgent Call to Review the U.S. Pharmaceuticals Supply Chain” for Anthony Sardella’s testimony at the House Subcommittee on Oversight and Investigations in May. The article cited Sardella’s research conducted through the Center for Analytics and Business Insights at Washington University in St. Louis. The research found that 30% of U.S. generic pharmaceutical manufacturing sites are operating at less than 50% utilization.

Read the Full SCB Article